Article Text

Download PDFPDF
Associations between renal deposits of complement factors, disease activity and loss of renal function in lupus nephritis
  1. Jacob J E Koopman1,2,
  2. Helmut G Rennke3,
  3. Gearoid M McMahon2,
  4. Sushrut S Waikar4,
  5. Karen H Costenbader5
  1. 1Section of Clinical Immunology, Department of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands
  2. 2Division of Renal Medicine, Brigham and Women’s Hospital, Boston, Massachusetts, USA
  3. 3Department of Pathology, Brigham and Women’s Hospital, Boston, Massachusetts, USA
  4. 4Section of Nephrology, Boston University Medical Center, Boston, Massachusetts, USA
  5. 5Division of Rheumatology, Inflammation and Immunity, Brigham and Women’s Hospital, Boston, Massachusetts, USA
  1. Correspondence to Dr Jacob J E Koopman, Erasmus Medical Center, Rotterdam, 3015 GD, Netherlands; j.j.e.koopman{at}lumc.nl

Statistics from Altmetric.com

Although deposits of complement factors in a kidney biopsy are typical of lupus nephritis, their prognostic relevance had never been investigated until a year ago. Then, around the same time, Kim and colleagues published a study in which deposits were associated with loss of renal function,1 while we published a similar study that reported no such association.2 Here, we explore possible explanations for these seemingly conflicting findings.

Both studies assumed that deposits of C1q with or without C3 in glomeruli reflect activation of the classical pathway and that deposits of C3 without C1q in glomeruli reflect activation of only the alternative pathway of complement. Here, we refer to such patterns of deposits in short as classical and alternative deposits, respectively.

Both studies compared clinical and histopathological characteristics between patients with classical deposits and those with alternative deposits (table 1). Alternative deposits were found in a minority of similar sizes in both studies. In both studies, patients with alternative deposits had less active disease based on higher serum levels of C3 and C4, a lower disease activity index and a lower pathological activity index, …

View Full Text

Footnotes

  • Handling editor Stephen R A Jolles.

  • Contributors JJEK conceived and drafted the manuscript. All authors contributed to the interpretation of the data and the writing of the manuscript.

  • Funding This work was supported by the National Institutes of Health (grant numbers R01 AR057327, K24 AR066109) to KHC.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.